IBEX Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-36,004
Closed -$3.58M 114
2019
Q3
$3.58M Buy
36,004
+323
+0.9% +$30.7K 1.19% 30
2019
Q2
$3.3M Buy
35,681
+4,792
+16% +$455K 0.95% 35
2019
Q1
$2.91M Buy
+30,889
New +$2.7M 1.02% 33
2018
Q1
Sell
-25,334
Closed -$2.64M 123
2017
Q4
$2.64M Sell
25,334
-4,269
-14% -$482K 1.17% 37
2017
Q3
$4.12M Sell
29,603
-529
-2% -$72.1K 1.53% 17
2017
Q2
$3.98M Buy
30,132
+2,388
+9% +$293K 1.56% 16
2017
Q1
$3.44M Buy
27,744
+1,426
+5% +$171K 2.12% 14
2016
Q4
$2.96M Buy
26,318
+5,925
+29% +$660K 1.42% 24
2016
Q3
$2.13M Buy
+20,393
New +$2.21M 1.17% 30

Other funds holding CELG

IBEX Wealth Advisors's CELG Position: Q4 2019 in Review

IBEX Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36,004 shares — an estimated $3.58M sold.

IBEX Wealth Advisors first reported a position in CELG in Q3 2016 and held it in 9 quarters. The position peaked at $4.12M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • IBEX Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • IBEX Wealth Advisors sold 36,004 Celgene Corp shares in Q4 2019, an estimated $3.58M.
  • IBEX Wealth Advisors first reported a position in Celgene Corp in Q3 2016 and held it in 9 quarters.
  • IBEX Wealth Advisors's Celgene Corp position peaked at $4.12M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on IBEX Wealth Advisors's 13F filing for Q4 2019, filed 24 Jan 2020.